P3 Health Partners Inc (NAS:PIII)
$ 9.83 -0.46 (-4.47%) Market Cap: 32.69 Mil Enterprise Value: 341.61 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 43/100

Q2 2025 P3 Health Partners Inc Earnings Call Transcript

Aug 14, 2025 / 08:30PM GMT
Release Date Price: $6.94 (-2.25%)

Key Points

Positve
  • P3 Health Partners Inc (PIII) is nearing full execution on a $130 million EBITDA improvement plan, indicating strong operational progress.
  • The company successfully renegotiated a contract with a major payer, positioning them for approximately $20 million in contractual improvements.
  • P3 Health Partners Inc (PIII) reported a 10% year-over-year improvement in funding across its membership on a normalized per member basis.
  • The care enablement model is delivering accelerated results in clinical quality metrics, with significant improvements in care gap closures.
  • The company has identified an additional $120 to $170 million in EBIT improvements for 2026, driven by operational and contractual enhancements.
Negative
  • P3 Health Partners Inc (PIII) reported an adjusted EBITDA loss of $17 million for the quarter, with a significant portion tied to a single payer in a single market.
  • The company revised its full-year guidance to a loss range of $39 million to $69 million due to prior period headwinds and non-core asset performance.
  • Membership declined by 9% year-over-year, primarily due to the rationalization of payer and provider partnerships.
  • Capitated revenue decreased by 6% year-over-year, driven by the decline in membership.
  • The company faced unfavorable prior period adjustments totaling $9 million, impacting Q2 results negatively.
Operator

Good day and welcome to the Pre Health Partners, 2nd quarter 2025 earnings conference call.

All participants will be in the listener mode.

Should you need assistance, please signal a conference specialist by pressing the star key followed by 0.

After today's presentation there will be an opportunity to ask questions. You may press start then one on a touchstone phone.

Withdraw your question, please press 2.

Please note this event is being recorded.

I would now like to turn the conference over to Ryan Halstead. Please go ahead.

Ryan Halsted
Gilmartin Group LLC - Managing Director, Investor Relations

Thank you, operator, and thank you for joining us today.

Before we proceed with the call, I would like to remind everyone that certain statements made during this call are forward-looking statements under the US federal securities laws, including statements regarding our financial outlook and long term target.

These forward-looking statements are only predictions and are based largely on

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot